Business Wire

XPENG Launches G9 SUV and P7 Sedan for Europe

3.2.2023 10:00:00 EET | Business Wire | Press release

Share

XPENG (NYSE: XPEV and HKEX: 9868), today launched its two latest smart EV models for European markets: G9 flagship SUV, and the new P7 sports sedan. Both models, on show at eCar Expo in Stockholm Feb 3-5, are now available for order in Denmark, Norway, the Netherlands, and Sweden.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230202005580/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Premium electric smart sedan with sports car DNA (Photo: Business Wire)

“XPENG G9 and P7 bring a combination of superior styling, quality, performance and comfort, exemplifying our market-leading technology and innovation. Today also represents a significant milestone as we build our presence in Europe. We believe both vehicles deliver a new level of sophistication and a people-first mobility experience, and will be the electric vehicles of choice for many European customers,” said Brian Gu, Vice Chair and President of XPENG.

G9 features XPENG’s latest powertrain system, battery technology, and advanced driver assistance system (ADAS), fully complemented by a luxurious and immersive cabin experience. The new P7 - an upgraded version of P7 - combines its signature sports sedan profile with greater range, faster charging and a brand new smart cabin.

Faster Charging. Longer Range

XPENG’s new models bring some of the most powerful and advanced EV technology to Europe. XPENG G9 features a new powertrain system with 800 V Silicon Carbide (SiC) platform for ultra-fast charging of up to 300 kW, allowing drivers to add up to 100 km of range in just five minutes. This makes it possible to charge the 98 kWh battery from 10 % to 80% in just 20 minutes. G9 can travel up to 570 km WLTP on a single charge (RWD Long Range), exceptional for the battery size. G9 can be fitted with an electric tow bar, for up to 1,500 kg towed load, to suit European lifestyles.

The new P7 has been optimized with the maximum charging power of up to 175 kW, delivering fast charging from 10% to 80% in only 29 minutes. P7’s range has been improved, offering up to 576 km WLTP on a single charge (RWD Long Range). An electric tailgate and soft-closing doors are introduced for even greater comfort and convenience, along with a heat pump and heated steering wheel for more relaxing winter driving in the colder regions of Europe.

XPENG G9 and P7 are both engineered to meet E-NCAP five-star safety standards and stringent EU WVTA vehicle certification.

Superior Performance. Elegant Design

XPENG G9 and P7 boast superior performance with their advanced systems and elegant aerodynamic profiles, and are available in all-wheel-drive or rear-wheel drive configurations.

G9’s all-wheel drive version boasts up to 551 hp with a maximum torque of 717 Nm, powering acceleration from 0–100 km/h in just 3.9 seconds. The dual-chamber air spring system provides a wide range of stiffness adjustments to help the vehicle handle complex road conditions and ensure optimal ride comfort.

For the new P7, the all-wheel drive version accelerates from 0 to 100 km/h in just 4.1 seconds – outperforming even some sports car models. Brembo brakes also come as standard, giving drivers an extra level of control. All of this comes wrapped up in an exterior using XPENG's "Dynamic Aesthetics" design language that creates a more dynamic sports silhouette.

The new P7 is offered in a stunning range of colour styles, as well as an exclusive Wing Edition featuring scissors doors.

Both models adopt hidden door handles, with extremely low drag coefficients (0.236 for P7 and 0.272 for G9), for lower power consumption and extended range.

Comfort and Intelligence

The cabins of both vehicles use wraparound designs with high-quality finishing and materials to create a warm and comfortable environment. The ergonomically designed front seats feature heating and ventilation functions. To create an even more immersive cabin, both P7 and G9 can be configured with a Dynaudio sound system, producing up to 860 W and 2150 W respectively.

Both XPENG G9 and P7 come equipped with XPENG's proprietary Advanced Driver Assistance System, XPILOT, offering safety, driving, and parking support through a variety of smart functions. These functions are supported by 29 sensors including high-definition millimeter-wave radars, ultrasonic sensors, surround view and high perception cameras, enabling the vehicles to safely tackle multiple driving scenarios.

The upgraded in-car Xmart OS boasts a new 3D UI that supports English, Nederlands, Dansk, Norsk, and Svenska, depending on the market. Xmart OS also comes with the improved "Hey, XPENG" voice assistant, which can distinguish complex voice commands from all four zones of the cabin. These services are supported by wide infotainment screens and a library of in-car apps to assist, inform and entertain drivers and passengers.

G9 and P7 will also support easy and seamless over-the-air (OTA) updates that allow both software and firmware to be improved during normal use.

Expanding Service and Charging Networks

Delivery of the new models will capitalize on the opening of XPENG’s new Delivery and Service Centers in the key markets: at Lørenskog in Norway (opening February 2023), Badhoevedorp in the Netherlands, Stäket, Järfälla in Sweden and Hillerød in Denmark – all opening in the Q2 2023.

XPENG will also open additional authorized service locations with dedicated partners in key European countries by the end of 2023.

XPENG customers can access over 400,000 public charging stations in Europe, by collaboration with major European third-party charging operators and mobility service providers (Plugsurfing and Shell Recharge). With its new models, XPENG will provide third party home charger and installation services together with local partners, to offer customers a seamless easy charging experience.

Warranty

As a brand committed to product quality and offering better customer experiences, XPENG is proud to offer a five-year/120,000 km warranty* as standard for hassle-free ownership. For customers** ordering our new P7 sedan or G9 SUV between February 3 and December 31, 2023, the standard warranty will be extended to seven years/160,000 km from the date of delivery. This extended warranty is linked to the vehicle and is transferable when or if the vehicle is sold.

*For more information on the limited warranty policy, please refer to the warranty booklet.
**For more information on who is eligible for this extended warranty offer, please refer to the warranty booklet.

Pricing, Test Drive and Delivery

Expected starting prices* for the European version G9 are as follows

Model:

XPENG G9

Version

RWD Standard
Range

RWD Long
Range

AWD
Performance

Price(MSRP) - Norway (NOK)

499 900

569 900

639 900

Price(MSRP) - Sweden (SEK)

699 900

749 900

829 900

Price(MSRP) - Netherlands (EURO)

57 990

61 990

71 990

Price(MSRP) - Denmark (DKK)

479 900

549 900

599 900

Expected starting prices* for the new European version P7 are as follows

Model:

XPENG P7

Version

RWD Long Range

AWD Performance

Wing Edition

Price(MSRP) - Norway (NOK)

439 900

479 900

649 900

Price(MSRP) - Sweden (SEK)

599 900

669 900

799 900

Price(MSRP) - Netherlands (EURO)

49 990

59 990

69 990

Price(MSRP) - Denmark (DKK)

399 900

479 900

599 900

*All prices include VAT and exclude local taxes, registration fees, and delivery costs. Please contact local XPENG representatives for details.

Deliveries for the new P7 will begin in June and G9 deliveries are expected to commence in September.

Customers can contact XPENG’s experience stores (Oslo, The Hague, Stockholm, Copenhagen) for test drive schedules. For more information about the G9 and P7, please visit the dedicated local XPENG websites:

https://heyxpeng.com/no/p7
https://heyxpeng.com/se/p7
https://heyxpeng.com/dk/p7
https://heyxpeng.com/nl/p7
https://heyxpeng.com/no/g9
https://heyxpeng.com/se/g9
https://heyxpeng.com/dk/g9
https://heyxpeng.com/nl/g9

Presskit (visual assets and specs) link

Follow us:
XPENG Twitter
XPENG LinkedIn
XPENG Facebook
XPENG Instagram
XPENG TikTok
XPENG YouTube

About XPeng Inc.

XPeng is a leading Chinese Smart EV company that designs, develops, manufactures, and markets Smart EVs that appeal to the large and growing base of technology-savvy middle-class consumers. Its mission is to drive Smart EV transformation with technology and data, shaping the mobility experience of the future. In order to optimize its customers’ mobility experience, XPeng develops in-house its full-stack advanced driver-assistance system technology and in-car intelligent operating system, as well as core vehicle systems including powertrain and the electrical/electronic architecture. XPeng is headquartered in Guangzhou, China. In 2021, the Company established its European headquarters in Amsterdam, along with other dedicated offices in Copenhagen, Munich, Oslo, and Stockholm. The Company’s Smart EVs are mainly manufactured at its plant in Zhaoqing, Guangdong province. For more information, please visit https://heyxpeng.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For Media Enquiries:
Email: pr@xiaopeng.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye